Australia markets close in 5 hours 18 minutes

Osteopore Limited (OSX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0610+0.0020 (+3.39%)
As of 10:28AM AEST. Market open.

Osteopore Limited

191 Street Georges Terrace
Level 5
Perth, WA 6000
61 2 8072 1400

IndustryMedical Instruments & Supplies
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Kei Wei LeongExecutive Chairman150kN/A1976
Dr. Yujing LimCEO & CTO202.25kN/AN/A
Ms. Shu Ning VoonFinancial ControllerN/AN/AN/A
Mr. Khoon Seng GohGlobal Marketing Director212.9kN/AN/A
Ms. Kellie DavisCompany SecretaryN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally. The company commercializes a range of bespoke products to facilitate bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants. In addition, it sells medical devices; provides technology services; and engages in research and development. Osteopore Limited was incorporated in 2018 and is headquartered in Perth, Australia.

Corporate governance

Osteopore Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.